Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
13 April 2017Website:
http://www.fortebiorx.comNext earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Tue, 02 Jul 2024 20:45:23 GMTDividend
Analysts recommendations
Institutional Ownership
FBRX Latest News
Forte Biosciences (FBRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
What type of business is Forte Biosciences?
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
What sector is Forte Biosciences in?
Forte Biosciences is in the Healthcare sector
What industry is Forte Biosciences in?
Forte Biosciences is in the Biotechnology industry
What country is Forte Biosciences from?
Forte Biosciences is headquartered in United States
When did Forte Biosciences go public?
Forte Biosciences initial public offering (IPO) was on 13 April 2017
What is Forte Biosciences website?
https://www.fortebiorx.com
Is Forte Biosciences in the S&P 500?
No, Forte Biosciences is not included in the S&P 500 index
Is Forte Biosciences in the NASDAQ 100?
No, Forte Biosciences is not included in the NASDAQ 100 index
Is Forte Biosciences in the Dow Jones?
No, Forte Biosciences is not included in the Dow Jones index
When does Forte Biosciences report earnings?
The next expected earnings date for Forte Biosciences is 14 August 2024